Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 468 (RNA5SP468)

Target
RNA5SP468
Molecular classification
Other (Processed pseudogene), rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 468 (RNA5SP468) is a human genomic locus that originated from retrotransposition of a 5S ribosomal RNA gene, resulting in a processed pseudogene[1][2][7]. Unlike functional rRNA genes, processed pseudogenes lack promoters and may accumulate sequence deletions or mutations rendering them non-translatable and non-functional[5][6]. Pseudogenes of 5S rRNA, such as RNA5SP468, are common in mammalian genomes and represent a record of the evolutionary dynamics of rRNA gene families, but do not generally contribute to ribosome function or cellular biology[5][6]. These loci are typically not transcribed and have no protein product. While pseudogenes as a group have been implicated in some regulatory functions and disease associations through non-coding RNA activity or as regulators of their wild-type counterparts, no evidence links RNA5SP468 specifically to disease, biomarker utility, or therapeutic applications[8]. 5S ribosomal RNA is a highly conserved component of ribosomes, structurally essential for large subunit function[3][5]. Functional 5S rRNA genes in humans are distinct from their pseudogene counterparts, such as RNA5SP468, which are generally nonfunctional remnants retained in the genome after gene duplication and degeneration[5][6]. Genomic databases such as GeneCards, NCBI Gene, and BioGPS designate RNA5SP468 as a pseudogene, with no associated protein product or therapeutic relevance[1][2][7]. RNA5SP468 does not encode a receptor, enzyme, or transporter and should not be considered a conventional drug target[1][2][7].

Other names
RN5S468RNA, 5S ribosomal 468RNA5SP4685S rRNA pseudogene 468
02

Mechanism of action

None (No known mechanisms since it is not functional)

03

Biological functions

None (Non-functional, derived from 5S rRNA gene, considered genomic "fossil")[1][2][7].
04

Disease associations

Other (No direct role. Pseudogenes in general have been linked to disease association through regulatory effects, but no data support any specific disease involvement for RNA5SP468)[8].
05

Safety considerations

None (No therapeutic challenges reported)
06

Interacting drugs

None (No known drugs interact with this pseudogene)
07

Biomarkers

None (No evidence as clinical biomarker)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 468 (RNA5SP468).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 468 (RNA5SP468).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call